Relaxin inhibits renal fibrosis and the epithelial-to-mesenchymal transition via the Wnt/β-catenin signaling pathway

Renal fibrosis is a common characteristic and the final pathological mechanism of chronic kidney disease (CKD). Although CKD remains incurable, inhibition of renal fibrosis is beneficial to inhibit the CKD process. Relaxin alleviates renal fibrosis in some experimental models, but its mechanism rema...

Descripción completa

Detalles Bibliográficos
Autores principales: Feiteng, Chen, Lei, Chen, Deng, Li, Chaoliang, Xu, Zijie, Xu, Yi, Shao, Minglei, Sha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Laboratory Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942541/
https://www.ncbi.nlm.nih.gov/pubmed/35311469
http://dx.doi.org/10.1080/0886022X.2022.2044351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942541/
https://www.ncbi.nlm.nih.gov/pubmed/35311469
http://dx.doi.org/10.1080/0886022X.2022.2044351

Ejemplares similares